This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
A CERTIFIED AND GUARANTEED TOOL
Methodology for fast and simple pharmacogenetics
Our g-Nomic® software applies a three-step methodology that allows us to go from the most general – drug interactions with lifestyle habits or supplements – to the final verification with the patient’s genetic profile. All this with the guarantee of being certified by the Spanish Medicines Agency (AEMPS) as a “Medical Device”.
CHECK INTERACTIONS AND LIFESTYLE HABITS
3 steps to safe prescribing
1. Consult g-Nomic® and check interactions between medication and lifestyle.
2. Request a genetic test of the patient if necessary.
3. Generate a personalised pharmacogenetic report with g-Nomic®, combining genes and particular patient conditions to create a unique and personalised report.
CHECK INTERACTIONS AND LIFESTYLE HABITS
Discover the possible risks associated with a prescription.
Our constantly updated databases will allow you to discover interactions and risks between medication, lifestyle habits and supplements, as well as confirm genetic markers. Risk-free prescriptions, even without a genetic profile.
ONE PATIENT, ONE PRESCRIPTION
Unique and personalised reports for each patient
Each patient is unique and your prescription should be unique. With a genetic test, g-Nomic® will generate a personalised report considering all possible variables associated with your genetic markers. Pharmacogenetics is able to prescribe the right drug at the right dose for each patient according to their genes.
+79.000 M€
“79 billion a year in healthcare cost overruns due to adverse reactions, according to EU-EMA estimates. We are all genetically unique, and a drug treatment that works for one person may not work for another, not in terms of the drug itself or in terms of dosage”
+197.000
“More than 197,000 deaths in the EU due to adverse drug reactions. The correct application of pharmacogenetics reduces healthcare costs, minimises adverse drug reactions, avoids therapeutic failures and enables safe and efficient prescribing”
+40% ADRs
“More than 40% of adverse drug reactions (ADRs) could be avoided by applying pharmacogenetics. There are many drug agencies and consortia worldwide that recommend the use of pharmacogenetic criteria for individualised prescribing based on a person's genes”